Daniela Bacherini Selected Research

Daniela Bacherini Research Topics

9	Uveitis 06/2020 - 01/2017
8	Macular Degeneration (Age-Related Maculopathy) 08/2022 - 05/2014
8	Retinal Perforations 07/2021 - 01/2018
4	Retinal Detachment (Retinal Detachments) 09/2022 - 01/2018
4	Cataract (Cataracts) 07/2022 - 07/2017
4	Macular Edema 03/2021 - 01/2017
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 05/2014
3	Fabry Disease (Fabry's Disease) 01/2021 - 01/2019
3	Vasculitis (Vasculitides) 01/2017 - 01/2017
2	Epiretinal Membrane (Epiretinal Membranes) 03/2021 - 08/2017
2	Retinal Diseases 01/2021 - 09/2017
2	Atrophy 01/2019 - 01/2018
2	Retinal Vasculitis 07/2017 - 01/2017
1	Proliferative Vitreoretinopathy 09/2022
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 04/2022
1	COVID-19 11/2021
1	Amblyopia (Lazy Eye) 09/2021
1	Amyloidosis 01/2021
1	Transthyretin-Related Hereditary Amyloidosis 01/2021
1	Cavernous Hemangioma (Cavernous Angioma) 11/2020
1	Neoplasms (Cancer) 11/2020
1	Anterior Uveitis 06/2020
1	Choroidal Effusions 01/2019
1	Endophthalmitis (Ophthalmia) 01/2019
1	Myopia 01/2018
1	Prolapse 08/2017
1	Intraoperative Complications 08/2017
1	Hemorrhage 08/2017
1	Miosis 08/2017
1	Astigmatism 08/2017
1	Infections 02/2017
1	Tuberculosis (Tuberculoses) 02/2017
1	Inflammation (Inflammations) 01/2017
1	Muscle Hypotonia (Hypotonia) 08/2016
1	Cytomegalovirus Retinitis 03/2016
1	Retinal Vein Occlusion 03/2016
1	Geographic Atrophy 10/2015
1	Sarcoidosis (Schaumann Disease) 06/2013
1	Toxic Optic Neuropathy 02/2010
1	Ganglion Cysts (Ganglion) 02/2010

14	Retinaldehyde (Retinal)IBA 04/2022 - 02/2010
6	Fluorescein (Funduscein)FDA LinkGeneric 11/2020 - 05/2014
4	Adalimumab (Humira)FDA Link 06/2020 - 01/2017
4	Antirheumatic Agents (DMARD)IBA 01/2019 - 01/2017
3	SteroidsIBA 01/2019 - 01/2017
3	Dexamethasone (Maxidex)FDA LinkGeneric 07/2017 - 03/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 05/2014
2	Retinal Pigments (Pigments, Visual)IBA 01/2021 - 02/2010
2	Infliximab (Remicade)FDA Link 01/2019 - 02/2010
2	Biological ProductsIBA 01/2019 - 01/2017
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2017 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 01/2017
2	microplasminIBA 01/2017 - 08/2016
1	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2022
1	Sulfur HexafluorideIBA 04/2021
1	2,5-dichloro-4-bromophenol (B 2)IBA 03/2021
1	Prealbumin (Transthyretin)IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	golimumab FDA Link 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Complement System Proteins (Complement)IBA 12/2018
1	Immunomodulating AgentsIBA 07/2017
1	Interleukin-1 (Interleukin 1)IBA 01/2017
1	canakinumab FDA Link 01/2017
1	InterleukinsIBA 01/2017
1	N-acetyltryptophanamide (NATA)IBA 05/2014
1	Ranibizumab (Lucentis)FDA Link 05/2014
1	Rituximab (Mabthera)FDA Link 06/2013
1	Caspase 3 (Caspase-3)IBA 02/2010

6	Vitrectomy 09/2022 - 01/2017
4	Intravitreal Injections 10/2021 - 02/2010
3	Lasers (Laser) 07/2018 - 10/2015
2	Intraocular Lenses (Intraocular Lens) 07/2022 - 08/2017
2	Endotamponade 04/2021 - 01/2019
1	Phacoemulsification 03/2021
1	Operative Surgical Procedures 03/2021
1	Transplantation 01/2018
1	Biological Therapy 01/2018
1	Cataract Extraction 08/2017
1	Capsulorhexis 08/2017
1	Vitreoretinal Surgery 08/2017
1	Traction 01/2017
1	Light Coagulation 10/2015
1	Therapeutics 05/2014